Benefit of a High-Dose Epirubicin Regimen in Adjuvant Chemotherapy for Node-Positive Breast Cancer Patients With Poor Prognostic Factors: 5-Year Follow-Up Results of French Adjuvant Study Group 05 Randomized Trial
View Full Paper
Ask AI
Bookmark
Share
Discussion
Loading...
Member takes
Implication
Key Points
Key points are not available for this paper at this time.